ALKBH3 and neoplasm: Overall, our results demonstrate that ALKBH3-dependent m1A demethylation is essential for the formation of PML nuclear bodies, thereby providing a novel therapeutic strategy in which the ‘targeted m1A reprogramming strategy’ is efficient for tumor therapy.